MedTrace Logo

Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population

NCT00533754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-09-21

No results posted yet for this study

Summary

The aim of the study is to show a higher expression of the Y402H polymorphism in the complement factor H in patients with AMD compared to healthy individuals.

Additionaly a correlation between a subsided infection with chlamydia and patients with AMD and a factor H polymorphism will be investigated. An interrelationship with the VEGF-plasma level shall give more hints into the pathomechanism of AMD.

Conditions

  • Age-Related Macular Degeneration

Interventions

PROCEDURE

drawing blood

Sponsors & Collaborators

  • Rudolf Foundation Clinic

    lead OTHER

Principal Investigators

  • Susanne Binder, M.D. · Rudoulf Foundation Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2007-11-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533754 on ClinicalTrials.gov